Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Jan 21, 2025
- Accession no.
- 0001773751-25-000012
- Filed
- Jan 21, 2025
- Trade date
- Jan 16, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.27M. It was filed 5 days after the trade.
This filing was later replaced by the amendment 0001773751-25-000014 (Jan 23, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +33,668 | $2.43 | +$81,813.24 | 64,378 | Direct | |
| Jan 16, 2025 | Class A Common Stock | SSaleDisposed | −25,915 | $27.03F2 | −$700,482.45 | 38,463 | Direct | |
| Jan 16, 2025 | Class A Common Stock | SSaleDisposed | −7,753 | $27.22F3 | −$211,036.66 | 30,710 | Direct | |
| Jan 16, 2025 | Class A Common Stock | SSaleDisposed | −1,692 | $27.04F4 | −$45,751.68 | 29,018 | Direct | |
| Jan 16, 2025 | Class A Common Stock | SSaleDisposed | −1,100 | $27.40F3 | −$30,140 | 27,918 | Direct | |
| Jan 16, 2025 | Class A Common Stock | SSaleDisposed | −40,553 | $26.96F5 | −$1,093,308.88 | 482,311 | Indirect | |
| Jan 16, 2025 | Class A Common Stock | SSaleDisposed | −6,981 | $27.28F6 | −$190,441.68 | 475,330 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −33,668 | $0.00 | $0 | 1,531,067 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.70 - $27.115. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.12 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.01 - $27.085. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.72 - $27.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.125 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.